Dive into the science of precision cancer medicine at Knight School

Targeted therapy drugs have transformed the outlook for people diagnosed with one form of blood cancer, chronic myeloid leukemia. A disease with a three- to five-year life expectancy became, for...

Big milepost for a Knight Cancer scientist: 1000 papers

Gordon Mills, M.D., Ph.D., was fresh out of college when his first journal article appeared in 1976. He’s been quite busy since then, with a publication count that just hit quadruple...

Introducing Knight School

A new series of science talks produced by the OHSU Knight Cancer Institute debuts this month in Portland. Researchers, clinicians and patients are going on stage to present interconnected stories of...

Cancer Translated’s top blog posts of the year

Developing exercise as "medicine" for cancer. Questioning guidelines for off-label use of cancer drugs. Using a common pain reliever to reduce breast cancer risks. These were some of the most...

What magnitude of benefit is meaningful to cancer patients?

Oncologists often use the phrase "clinically meaningful benefit" to describe the effect of an experimental treatment. But is the benefit meaningful for patients? A new paper suggests that benefit...

Clearing the quandary of cancer early detection

For many cancers, five-year survival rates approach 99 percent if the disease is detected early, when tumors are small and not yet spreading. But efforts to detect cancers early have led to a...

When evidence contradicts entrenched medical practices

Medical reversal is the phenomenon when a medical practice falls out of favor not by being surpassed, but when researchers discover that it didn't really work all along. “I think the lesson of...

Charting the financial conflicts of doctors on Twitter

A detailed look at the tweeting habits of more than 600 hematologist-oncologists found that 72 percent were recipients of industry money for consulting, travel, lodging, or food and beverage. It's...